1文献来源Kansara R,Shenkier TN,Connors JM,et al.Rituximab with high-dose Methotrexate in primary central nervous system lymphoma[J].Am J Hematol,2015,90（12）：1149-1154.2证据水平2a。
1文献来源Younes A,Sehn L H,Johnson P,et al. Randomized phase Ⅲ trial of Ibrutinib and Rituximab plus Cyclophosphamide,Doxorubicin,Vincristine,and Prednisone in non-germinal center B-cell diffuse large B-cell lymphoma...1文献来源Younes A,Sehn L H,Johnson P,et al. Randomized phase Ⅲ trial of Ibrutinib and Rituximab plus Cyclophosphamide,Doxorubicin,Vincristine,and Prednisone in non-germinal center B-cell diffuse large B-cell lymphoma[J]. J Clin Oncol,2019,37(15):1285-1295.2证据水平1b。3背景弥漫大B细胞淋巴瘤(diffuse large B-celllymphoma,DLBCL)是最为常见的一种淋巴瘤。展开更多
文摘1文献来源Kansara R,Shenkier TN,Connors JM,et al.Rituximab with high-dose Methotrexate in primary central nervous system lymphoma[J].Am J Hematol,2015,90（12）：1149-1154.2证据水平2a。
文摘1文献来源Younes A,Sehn L H,Johnson P,et al. Randomized phase Ⅲ trial of Ibrutinib and Rituximab plus Cyclophosphamide,Doxorubicin,Vincristine,and Prednisone in non-germinal center B-cell diffuse large B-cell lymphoma[J]. J Clin Oncol,2019,37(15):1285-1295.2证据水平1b。3背景弥漫大B细胞淋巴瘤(diffuse large B-celllymphoma,DLBCL)是最为常见的一种淋巴瘤。
